Genetron Health
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A precision oncology company focused on NGS-based cancer diagnostics and drug development.
OncologyDiagnosticsGenetics & Genomics
Technology Platform
Proprietary NGS and bioinformatics platform for liquid biopsy and tissue-based cancer genomic profiling, coupled with a drug discovery engine.
Opportunities
Major opportunity in the large, underserved market for multi-cancer early detection (MCED) screening in China.
Risk Factors
Execution risk in managing capital-intensive, divergent diagnostics and drug development businesses simultaneously amid a challenging funding environment.
Competitive Landscape
Faces intense competition in the crowded oncology NGS testing market and must prove its therapeutic pipeline can succeed against established biopharma companies.